Form 4: CalciMedica Executive Eric W. Roberts Reports Stock Option Grant
SEC Filing
Eric W. Roberts, Chief Business Officer of CalciMedica, Inc., reports the acquisition of stock options.
Summary
- Eric W. Roberts, the Chief Business Officer of CalciMedica, Inc., filed a Form 4 with the SEC.
- The filing reports the grant of employee stock options.
- Roberts acquired options to purchase 77,500 shares of CalciMedica common stock at an exercise price of $4.16 on August 27, 2024.
- The options vest in equal monthly installments over a four-year period following March 28, 2024, with an expiration date of August 26, 2034.
- Following the transaction, Roberts directly owns 77,500 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing regarding stock option grants, which is neutral in sentiment.
Future Outlook
The filing does not contain any forward-looking statements regarding the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation structure and equity ownership of company executives.
Stakeholder Impact
- The granting of stock options aligns the interests of the executive with those of the shareholders, potentially incentivizing value creation.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Vesting start date for the stock options. |
| 08/27/2024 | Date of the stock option grant. |
| 08/26/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.